- Browse by Author
Browsing by Author "Patel, Ashish"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma(Impact Journals, 2015) Rajbhandari, Rajani; McFarland, Braden C.; Patel, Ashish; Gerigk, Magda; Gray, Kenneth; Fehling, Samuel C.; Bredel, Markus; Berbari, Nicolas F.; Kim, Hyunsoo; Marks, Margaret P.; Meares, Gordon P.; Sinha, Tanvi; Chuang, Jeffrey; Benveniste, Etty N.; Nozell, Susan E.; Biology, School of ScienceGlioblastomas (GBMs) are deadly tumors of the central nervous system. Most GBM exhibit homozygous deletions of the CDKN2A and CDKN2B tumor suppressors at 9p21.3, although loss of CDKN2A/B alone is insufficient to drive gliomagenesis. MIR31HG, which encodes microRNA-31 (miR-31), is a novel non-coding tumor suppressor positioned adjacent to CDKN2A/B at 9p21.3. We have determined that miR-31 expression is compromised in >72% of all GBM, and for patients, this predicts significantly shortened survival times independent of CDKN2A/B status. We show that miR-31 inhibits NF-κB signaling by targeting TRADD, its upstream activator. Moreover, upon reintroduction, miR-31 significantly reduces tumor burden and lengthens survival times in animal models. As such, our work identifies loss of miR-31 as a novel non-coding tumor-driving event in GBM.